Driehaus Capital Management’s Immunomedics Inc IMMU Stock Holding History

Driehaus Capital Management’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-204,000	Closed	-$17.3M	–	504
2020 Q3	$17.3M	Buy	+204,000	New	+$10.3M	0.36%	80
2017 Q4	–	Sell	-785,339	Closed	-$11M	–	629
2017 Q3	$11M	Buy	785,339 +72,649	+10%	+$724K	0.43%	57
2017 Q2	$6.29M	Buy	+712,690	New	+$5M	0.23%	100

Driehaus Capital Management's IMMU Position: Q4 2020 in Review

Driehaus Capital Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 204,000 shares — an estimated $17.3M sold.

Driehaus Capital Management first reported a position in IMMU in Q2 2017 and held it in 3 quarters. The position peaked at $17.3M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Driehaus Capital Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Driehaus Capital Management sold 204,000 Immunomedics Inc shares in Q4 2020, an estimated $17.3M.
Driehaus Capital Management first reported a position in Immunomedics Inc in Q2 2017 and held it in 3 quarters.
Driehaus Capital Management's Immunomedics Inc position peaked at $17.3M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Driehaus Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.